Xue Ying-wei, Yu Xue-feng
Department of Gastrointestinal Surgery, The Third Affiliated Hospital, Harbin Medical University, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Feb;16(2):125-7.
Recently, the incidence of carcinoma at the esophagogastric junction (CEG), especially adenocarcinoma at esophagogastric junction (AEG) is increasing. AEG has obvious difference from other parts of stomach tumor in anatomy, physiology and pathology. The scholars have not made a consensus and standard about the treatment of AEG. It is necessary to improve the knowledge and cognition about AEG and find a feasible treatment strategy.
近年来，食管胃交界部癌（CEG）的发病率，尤其是食管胃交界部腺癌（AEG）呈上升趋势。AEG在解剖学、生理学和病理学方面与胃肿瘤的其他部位存在明显差异。对于AEG的治疗，学者们尚未达成共识和标准。有必要提高对AEG的认识和了解，并找到可行的治疗策略。
